180 related articles for article (PubMed ID: 12149139)
1. Transgenic rats carrying human c-Ha-ras proto-oncogene are highly susceptible to N-nitrosomethylbenzylamine induction of esophageal tumorigenesis.
Asamoto M; Toriyama-Baba H; Ohnishi T; Naito A; Ota T; Ando A; Ochiya T; Tsuda H
Jpn J Cancer Res; 2002 Jul; 93(7):744-51. PubMed ID: 12149139
[TBL] [Abstract][Full Text] [Related]
2. Transgenic rats carrying human c-Ha-ras proto-oncogenes are highly susceptible to N-methyl-N-nitrosourea mammary carcinogenesis.
Asamoto M; Ochiya T; Toriyama-Baba H; Ota T; Sekiya T; Terada M; Tsuda H
Carcinogenesis; 2000 Feb; 21(2):243-9. PubMed ID: 10657964
[TBL] [Abstract][Full Text] [Related]
3. Transgenic rats carrying copies of the human c-Ha-ras proto-oncogene exhibit enhanced susceptibility to N-butyl-N-(4-hydroxybutyl)nitrosamine bladder carcinogenesis.
Ota T; Asamoto M; Toriyama-Baba H; Yamamoto F; Matsuoka Y; Ochiya T; Sekiya T; Terada M; Akaza H; Tsuda H
Carcinogenesis; 2000 Jul; 21(7):1391-6. PubMed ID: 10874018
[TBL] [Abstract][Full Text] [Related]
4. High susceptibility of transgenic rats carrying the human c-Ha-ras proto-oncogene to chemically-induced mammary carcinogenesis.
Tsuda H; Asamoto M; Ochiya T; Toriyama-Baba H; Naito A; Ota T; Sekiya T; Terada M
Mutat Res; 2001 Jun; 477(1-2):173-82. PubMed ID: 11376698
[TBL] [Abstract][Full Text] [Related]
5. Rapid induction of skin and mammary tumors in human c-Ha-ras proto-oncogene transgenic rats by treatment with 7,12-dimethylbenz[a]anthracene followed by 12-O-tetradecanoylphorbol 13-acetate.
Park CB; Fukamachi K; Takasuka N; Han BS; Kim CK; Hamaguchi T; Fujita K; Ueda S; Tsuda H
Cancer Sci; 2004 Mar; 95(3):205-10. PubMed ID: 15016318
[TBL] [Abstract][Full Text] [Related]
6. Incidence and effects of Ha-ras codon 12 G-->A transition mutations in preneoplastic lesions induced by N-nitrosomethylbenzylamine in the rat esophagus.
Liston BW; Gupta A; Nines R; Carlton PS; Kresty LA; Harris GK; Stoner GD
Mol Carcinog; 2001 Sep; 32(1):1-8. PubMed ID: 11568970
[TBL] [Abstract][Full Text] [Related]
7. Induction of esophageal tumors in zinc-deficient rats by single low doses of N-nitrosomethylbenzylamine (NMBA): analysis of cell proliferation, and mutations in H-ras and p53 genes.
Fong LY; Lau KM; Huebner K; Magee PN
Carcinogenesis; 1997 Aug; 18(8):1477-84. PubMed ID: 9276619
[TBL] [Abstract][Full Text] [Related]
8. G-->A mutations in p53 and Ha-ras genes in esophageal papillomas induced by N-nitrosomethylbenzylamine in two strains of rats.
Lozano JC; Nakazawa H; Cros MP; Cabral R; Yamasaki H
Mol Carcinog; 1994 Jan; 9(1):33-9. PubMed ID: 8297483
[TBL] [Abstract][Full Text] [Related]
9. High susceptibility of human c-Ha-ras proto-oncogene transgenic rats to carcinogenesis: a cancer-prone animal model.
Tsuda H; Fukamachi K; Ohshima Y; Ueda S; Matsuoka Y; Hamaguchi T; Ohnishi T; Takasuka N; Naito A
Cancer Sci; 2005 Jun; 96(6):309-16. PubMed ID: 15958052
[TBL] [Abstract][Full Text] [Related]
10. Incidence of Harvey ras oncogene point mutations and their expression in methylbenzylnitrosamine-induced esophageal tumorigenesis.
Barch DH; Jacoby RF; Brasitus TA; Radosevich JA; Carney WP; Iannaccone PM
Carcinogenesis; 1991 Dec; 12(12):2373-7. PubMed ID: 1747941
[TBL] [Abstract][Full Text] [Related]
11. Mutational activation of the cellular Harvey ras oncogene in rat esophageal papillomas induced by methylbenzylnitrosamine.
Wang Y; You M; Reynolds SH; Stoner GD; Anderson MW
Cancer Res; 1990 Mar; 50(5):1591-5. PubMed ID: 2406014
[TBL] [Abstract][Full Text] [Related]
12. Mutation in the p53 tumor suppressor gene in rat esophageal papillomas induced by N-nitrosomethylbenzylamine.
Wang D; Weghorst CM; Calvert RJ; Stoner GD
Carcinogenesis; 1996 Apr; 17(4):625-30. PubMed ID: 8625469
[TBL] [Abstract][Full Text] [Related]
13. Preferential mammary carcinogenic effects of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in human c-Ha-ras proto-oncogene transgenic rats.
Naito A; Suzuki A; Ueda S; Nomoto H; Toriyama-Baba H; Asamoto M; Tsuda H
Cancer Sci; 2004 May; 95(5):399-403. PubMed ID: 15132766
[TBL] [Abstract][Full Text] [Related]
14. Possible application of human c-Ha-ras proto-oncogene transgenic rats in a medium-term bioassay model for carcinogens.
Ohnishi T; Fukamachi K; Ohshima Y; Jiegou X; Ueda S; Iigo M; Takasuka N; Naito A; Fujita K; Matsuoka Y; Izumi K; Tsuda H
Toxicol Pathol; 2007 Apr; 35(3):436-43. PubMed ID: 17474063
[TBL] [Abstract][Full Text] [Related]
15. Lack of effect of human c-Ha-ras proto-oncogene overexpression on prostate carcinogenesis in probasin/SV40 T antigen transgenic rats.
Hokaiwado N; Asamoto M; Cho YM; Tsuda H; Shirai T
Cancer Sci; 2003 Dec; 94(12):1042-5. PubMed ID: 14662018
[TBL] [Abstract][Full Text] [Related]
16. Rapid induction of skin tumors in human but not mouse c-Ha-ras proto-oncogene transgenic mice by chemical carcinogenesis.
Muto S; Katsuki M; Horie S
Cancer Sci; 2006 Sep; 97(9):842-7. PubMed ID: 16805855
[TBL] [Abstract][Full Text] [Related]
17. Mammary carcinomas induced in human c-Ha-ras proto-oncogene transgenic rats are estrogen-independent, but responsive to d-limonene treatment.
Asamoto M; Ota T; Toriyama-Baba H; Hokaiwado N; Naito A; Tsuda H
Jpn J Cancer Res; 2002 Jan; 93(1):32-5. PubMed ID: 11802805
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of tongue carcinogenesis in Hras128 transgenic rats treated with 4-nitroquinoline 1-oxide.
Naoi K; Sunagawa N; Yoshida I; Morioka T; Nakashima M; Ishihara M; Fukamachi K; Itoh Y; Tsuda H; Yoshimi N; Suzui M
Oncol Rep; 2010 Feb; 23(2):337-44. PubMed ID: 20043093
[TBL] [Abstract][Full Text] [Related]
19. Piroxicam is an ineffective inhibitor of N-nitrosomethylbenzylamine-induced tumorigenesis in the rat esophagus.
Carlton PS; Gopalakrishnan R; Gupta A; Liston BW; Habib S; Morse MA; Stoner GD
Cancer Res; 2002 Aug; 62(15):4376-82. PubMed ID: 12154043
[TBL] [Abstract][Full Text] [Related]
20. Chemically induced lung and forestomach neoplasias in transgenic mice carry mutant forms of the human c-Ha-ras transgene.
Ogawa K; Imaida K; Masui T; Kawabe M; Hasegawa R; Kato K; Ito N; Shirai T
Carcinogenesis; 1996 Feb; 17(2):341-5. PubMed ID: 8625461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
